Assay | DNA/RNA | Gene | Selected SNV hotspots | CNVs | Fusions | Extra |
Oncomine Breast cfDNA Assay v2 | DNA | AKT1 CCND1 EGFR ERBB2 ERBB3 ESR1 FBXW7 FGFR1 KRAS PIK3CA SF3B1 TP53 | >150 hotspots including: PIK3CA: E545K, H1047R AKT1: E17KESR1: mutations associated with anti- estrogen resistance TP53: mutations associated with loss of functionERBB2: mutations associated with sensitivity to anti-ERBB2 therapies | CCND1, ERBB2, FGFR1 | — | Expanded coverage of TP53 |